Chargement en cours...

EXTH-47. PRECISION IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA USING CANCER IMMUNOGENOMICS AND SELECTIVE GENE ENRICHMENT STRATEGY

BACKGROUND: Development of successful immunotherapy targeting antigens in Glioblastoma (GBM) remains a challenge owing to the heterogeneous nature of GBM and the low mutation burden. It is therefore important to identify multiple tumor antigens that can be targeted simultaneously. Our goal is to dev...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Trivedi, Vrunda, Yang, Changlin, Yegorov, Oleg, Dyson, Kyle, Mitchell, Duane
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651008/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.401
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!